1. Home
  2. BNR vs GRF Comparison

BNR vs GRF Comparison

Compare BNR & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • GRF
  • Stock Information
  • Founded
  • BNR 2014
  • GRF 1989
  • Country
  • BNR China
  • GRF United States
  • Employees
  • BNR N/A
  • GRF N/A
  • Industry
  • BNR Medical Specialities
  • GRF Finance/Investors Services
  • Sector
  • BNR Health Care
  • GRF Finance
  • Exchange
  • BNR Nasdaq
  • GRF Nasdaq
  • Market Cap
  • BNR 38.3M
  • GRF 42.6M
  • IPO Year
  • BNR 2020
  • GRF N/A
  • Fundamental
  • Price
  • BNR $13.46
  • GRF $10.69
  • Analyst Decision
  • BNR
  • GRF
  • Analyst Count
  • BNR 0
  • GRF 0
  • Target Price
  • BNR N/A
  • GRF N/A
  • AVG Volume (30 Days)
  • BNR 28.1K
  • GRF 3.0K
  • Earning Date
  • BNR 12-02-2025
  • GRF 01-01-0001
  • Dividend Yield
  • BNR N/A
  • GRF 3.70%
  • EPS Growth
  • BNR N/A
  • GRF N/A
  • EPS
  • BNR N/A
  • GRF 1.16
  • Revenue
  • BNR $74,862,782.00
  • GRF N/A
  • Revenue This Year
  • BNR $136.32
  • GRF N/A
  • Revenue Next Year
  • BNR N/A
  • GRF N/A
  • P/E Ratio
  • BNR N/A
  • GRF $8.15
  • Revenue Growth
  • BNR 5.20
  • GRF N/A
  • 52 Week Low
  • BNR $2.18
  • GRF $7.93
  • 52 Week High
  • BNR $13.68
  • GRF $10.19
  • Technical
  • Relative Strength Index (RSI)
  • BNR 74.95
  • GRF 58.23
  • Support Level
  • BNR $12.00
  • GRF $10.55
  • Resistance Level
  • BNR $13.19
  • GRF $10.80
  • Average True Range (ATR)
  • BNR 0.85
  • GRF 0.24
  • MACD
  • BNR 0.41
  • GRF -0.01
  • Stochastic Oscillator
  • BNR 96.13
  • GRF 39.53

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About GRF Eagle Capital Growth Fund Inc.

Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.

Share on Social Networks: